Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

Supplementary Figure 1 from Combination ATR (ceralasertib) and PARP (olaparib) Inhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer

<p>Trial schema</p>

Uloženo v:
Podrobná bibliografie
Hlavní autor: Stephanie L. Wethington (16354020) (author)
Další autoři: Payal D. Shah (14942077) (author), Lainie Martin (16354023) (author), Janos L. Tanyi (15047976) (author), Nawar Latif (16354026) (author), Mark Morgan (16354029) (author), Drew A. Torigian (15047964) (author), Diego Rodriguez (16354032) (author), Simon A. Smith (16354035) (author), Emma Dean (16354038) (author), Susan M. Domchek (14944434) (author), Ronny Drapkin (14937867) (author), Ie-Ming Shih (14964062) (author), Eric J. Brown (16354041) (author), Wei-Ting Hwang (15045089) (author), Deborah K. Armstrong (15134754) (author), Stephanie Gaillard (14947156) (author), Robert Giuntoli (16354044) (author), Fiona Simpkins (15048000) (author)
Vydáno: 2025
Témata:
Cancer
Therapeutic Research and Development
Clinical Research and Trials
Clinical Trial Results
Drug Resistance
Gynecological Cancers
Ovarian cancer
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Buďte první, kdo okomentuje tento záznam!
Nejprve se musíte přihlásit.

Podobné jednotky